Tizanidine
Product Images NDC 50436-6755

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50436-6755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

This is a chart that shows the plasma concentration of Tzanidine in ng/mL over time after taking two different forms of the medication (tablets and capsules) with and without food. There are no additional details provided in the text.*

FDA Label Image

Fig2 (Fig2)

The text is showing a graph with the title "Improvement in Ashworth Score". There are two plots on the graph, one labeled "16 mg tizanidine" and the other labeled "placebo". The x-axis is labeled "Hours Post-Dose". Unfortunately, there is no further information on what this graph represents or the context in which it was created.*

FDA Label Image

Fig3 (Fig3)

The text describes a study assessing the improvement in Ashworth Score for patients that were administered a mean dose of 28.6mg of Zanidine at both week 3 and week 7 during maintenance endpoint. The study utilized a Last Observation Garred Forward approach.*

FDA Label Image

Label Image (Lbl504366755)

This is a warning label for a medication called Tizanidine. The label provides information on the manufacturer, National Drug Code, lot number, expiration date, and dosage of the medication. It also includes a warning message.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.